Vedolizumab vs. ustekinumab for Crohn's disease: comparative effectiveness in a real-life observational cohort study (ICC case series)

Dutch Initiative on Crohn and Colitis

Research output: Contribution to journalMeeting AbstractAcademic

Cite this